Top Gynecology & Infertility Medicines Company in India - Adorefem

  Well, today, each pharma entrepreneur is aware of the fact that gynecology is one of the profitable niches in the healthcare industry. Therefore, a huge proportion of professionals jump into this segment with a vision to gain significant profits. However, it is often seen that to touch newer heights, entrepreneurs think that adding expanding product list is an ideal choice. But in reality, it is not. Sales often seem to depend on how often a product gets prescribed.  So, this brings a debate among the entrepreneurs that what really matters, whether it's Prescription Velocity or Brand Count. To clear out this confusion, Adorefem, a leading gynecology pharma company , has curated this blog. Explore it in detail! What is Prescription Velocity in Gynecology? It refers to how frequently a gynecologist prescribes a specific product over time. In gynae practice, doctors rely heavily on clinical outcomes, patient compliance, and consistency across cases. Once a product proves effect...

Gynecology has become a rapidly growing pharma segment. It's because of increasing awareness of women’s health, rising demand for trusted products, and expanding clinical practices. However, in this vast women's care medicine market, not all products are onboarded by top-performing distributors. For the selection of a brand, they have first evaluated depending on several factors, such as market reputation, affordability, and effectiveness. All these will be discussed later in this blog. Adorefem is a trusted gynecology pharma company whose products are strongly recognized in the market and widely trusted by reputable doctors. They have curated some influential factors that successful gynae distributors look for in a pharma partner.  What High-Performing Gynae Distributors Look for Before Onboarding a Pharma Brand? In India, many pharma companies specialize in making gynae products with care and precision. Also, according to Grand View Research, this market is growing at a CAGR...